The fight against Tuberculosis is entering a new era, with both effort to control and deliberate strides to end the epidemic through reduced new infections and mortality by 2035 taking shape. This is important towards the realization of Universal Health Coverage in line with the SGD 3.8. Through the ‘End TB strategy’ one of the targets addresses the catastrophic total cost incurred by TB patients and their families. In line with this, Kenya saw the launch of the first National TB Patient Cost Survey on 5th July 2018.
China has earned global recognition following its remarkable success in reducing new HIV infections among people who inject drugs. China has one of the biggest Methadone Maintenance Treatment (MMT) programs in the world with more than 762 MMT centres, treating over 200,000 drug users. To learn more on this KANCO with the support of the International HIV/AIDS Alliance joined the UNODC, UNAIDS representatives from China, Kenya, Tanzania, and South Africa and delegates from the Republics of Kenya, Tanzania & Uganda, and National Health Commission of the People’s Republic of China for a Horizontal Learning Exchange visit.
In this issue:
- KANCO in Regional Technical Study Tour on Methadone Take home Dose to China
- Kenya Launches the First National TB Cost Survey
- Mama and Totos Corner: Weaning